The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients

Sponsor
Istanbul Kültür University (Other)
Overall Status
Completed
CT.gov ID
NCT03827746
Collaborator
Marmara University (Other), Istanbul University-Cerrahpasa (Other)
60
1
18
3.3

Study Details

Study Description

Brief Summary

The kinesiophobia; defined as irrational fear of movement, which may occur after painful injury and reduce physical activity. It develops the idea that movement in individuals will cause re-injury and cause additional pain to existing pain. Studies have shown that this situation leads to a decrease in physical fitness, avoidance of activity, decrease in quality of life and even depression in the long term. It is known that functional problems such as balance problems and decrease in physical activity level occur in patients with Parkinson's disease. However, in the literature, there is no study investigating the presence of kinesiophobia in patients with Parkinson's disease. Therefore, the aims of our study were to

  1. determine the presence / absence of kinesiophobia in patients with Parkinson's disease 2) determine the relationship between kinesiophobia and falling, balance, physical activity level in the presence of kinesiophobia.
Condition or Disease Intervention/Treatment Phase
  • Other: Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy Scale

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
The Effect of Kinesiophobia on Physical Activity, Balance and Falling in Parkinson's Disease Patients
Actual Study Start Date :
Apr 1, 2018
Actual Primary Completion Date :
Apr 1, 2019
Actual Study Completion Date :
Oct 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Tampa Kinesiophobia Scale (TSK) [10 minutes]

    It is a 17-item self report checklist using a 4-point Likert scale

  2. Berg-Balance Test [15-20 minutes]

    14-item scale designed to measure balance of the older adult in a clinical setting. Scoring: A five-point ordinal scale, ranging from 0-4. "0" indicates the lowest level of function and "4" the highest level of function. Total Score = 56 41-56 = low fall risk 21-40 = medium fall risk 0 -20 = high fall risk

  3. Falls Efficacy Scale [5-7 minutes]

    It is a 10 item scale where each item is rated on a scale of 1-10. A score of 10 signifies no confidence in these activities; a score of 1 indicates confidence. Out of a total score of 100, a score of 70 or above indicates the individual has a fear of falling.

  4. International Physical Activity Questionnaire - Short form [5-10 minutes]

    This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. Walking = 3.3 METs Moderate Intensity = 4.0 METs Vigorous Intensity = 8.0 METs Total MET-minutes/week = Walk (METs*min*days) + Mod (METs*min*days) + Vig (METs*min*days) 1. Low: • No activity is reported OR • Some activity is reported but not enough to meet Categories 2 or 3. 2. Moderate: • 3 or more days of vigorous activity of at least 20 minutes per day OR • 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day OR • 5 or more days of any combination of walking, moderate-intensity or vigorousintensity activities achieving a minimum of at least 600 MET-minutes/week. 3. High: • Vigorous-intensity activity on at least 3 days and accumulating at least 1500 MET-minutes/week OR • 7 or more days of any combination of walki

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being diagnosed with Parkinson's disease according to the criteria of United Kingdom Brain Bank and diagnosed as Parkinson's disease by neurologist

  • According to Hoehn-Yahr scale 1-3

  • Mini-Mental Test score 24 and above

Exclusion Criteria:
  • Another disease that will prevent walking

  • Visual impairment and vestibular dysfunction

  • Cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marmara University Istanbul Turkey

Sponsors and Collaborators

  • Istanbul Kültür University
  • Marmara University
  • Istanbul University-Cerrahpasa

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gamze Ertürk, Research assistant, Istanbul Kültür University
ClinicalTrials.gov Identifier:
NCT03827746
Other Study ID Numbers:
  • 09.2017.226
First Posted:
Feb 1, 2019
Last Update Posted:
Feb 18, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gamze Ertürk, Research assistant, Istanbul Kültür University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2021